Recent Company News

• 02:30 PM ET Feb 13, 2026
  

  Robbins LLP Recommends That MREO Investors Who Incurred Significant Losses Contact The Firm For Information About Leading The Mereo BioPharma Group plc Class Action

• 07:21 AM ET Feb 13, 2026
  

  MREO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

• 07:03 AM ET Feb 13, 2026
  

  Pomerantz LLP Advises Shareholders of Class Action Filing Involving Mereo BioPharma Group plc - MREO

• 07:43 PM ET Feb 12, 2026
  

  ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MREO

• 06:50 PM ET Feb 12, 2026
  

  INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

• 02:59 PM ET Feb 12, 2026
  

  Mereo BioPharma Group plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights - MREO

• 09:55 AM ET Feb 12, 2026
  

  MREO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

• 07:01 AM ET Feb 12, 2026
  

  MREO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

• 08:23 PM ET Feb 11, 2026
  

  MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

• 09:39 AM ET Feb 11, 2026
  

  MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026